Literature DB >> 30032349

Cellular distribution of CD200 receptor in rats and its interaction with cytomegalovirus e127 protein.

Mohamed A El-Mokhtar1,2, Agnieszka Bauer1, Julia Madela1, Sebastian Voigt3,4.   

Abstract

CD200 is a membrane protein that interacts with CD200R on the surface of immune cells and delivers an inhibitory signal. In this study, we characterized the distribution of inhibitory CD200R in rats. In addition, we investigated if e127, a homologue of rat CD200 expressed by rat cytomegalovirus (RCMV), can suppress immune functions in vitro. RT-PCR analysis was carried out to test the expression of CD200R in different rat tissues and flow cytometry was performed to characterize CD200R at the cellular level. To test the inhibitory functions of e127, a co-culture system was utilized in which immune cells were incubated with e127-expressing cells. The strongest CD200R expression was detected in lymphoid organs such as bone marrow and spleen. Flow cytometry analyses showed that CD200R+ cells were mainly CD4- dendritic cells (DC) and CD4+ T cells in the spleen. In blood, nearly all monocytes and granulocytes expressed CD200R and in bone marrow the NKRP1low subset of natural killer cells highly expressed CD200R. In addition, both peritoneal macrophages and the NR8383 macrophage cell line carried CD200R. At the functional level, viral e127 conferred an inhibitory signal on TNFα and IL6 cytokine release from IFNγ-stimulated macrophages. However, e127 did not affect the cytotoxic activity of DC. CD200R in the rat is mainly expressed on myeloid cells but also on non-myeloid cell subsets, and RCMV e127 can deliver inhibitory signals to immune cells by engaging CD200R. The RCMV model provides a useful tool to study potential immune evasion mechanisms of the herpesviridae and opens new avenues for understanding and controlling herpesvirus infections.

Entities:  

Keywords:  CD200 receptor; Cytomegalovirus; Viral CD200 homologues; Viral immune evasion; e127 protein

Mesh:

Substances:

Year:  2018        PMID: 30032349     DOI: 10.1007/s00430-018-0552-3

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  64 in total

1.  CD200 as a prognostic factor in acute myeloid leukaemia.

Authors:  A Tonks; R Hills; P White; B Rosie; K I Mills; A K Burnett; R L Darley
Journal:  Leukemia       Date:  2007-01-25       Impact factor: 11.528

2.  Enhancement of the expression of a rat neutrophil-specific cell surface antigen by activation with phorbol myristate acetate and concanavalin A.

Authors:  S Gotoh; M Itoh; Y Fujii; S Arai; F Sendo
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

3.  Different reticular elements in rat lymphoid tissue identified by localization of Ia, Thy-1 and MRC OX 2 antigens.

Authors:  A N Barclay
Journal:  Immunology       Date:  1981-12       Impact factor: 7.397

4.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo.

Authors:  Cheryl M Cameron; John W Barrett; Liying Liu; Alexandra R Lucas; Grant McFadden
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.

Authors:  Gavin J Wright; Holly Cherwinski; Mildred Foster-Cuevas; Gary Brooke; Michael J Puklavec; Mike Bigler; Yaoli Song; Maria Jenmalm; Dan Gorman; Terri McClanahan; Man-Ru Liu; Marion H Brown; Jonathon D Sedgwick; Joseph H Phillips; A Neil Barclay
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

7.  Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine.

Authors:  F S Stals; A Zeytinoglu; M Havenith; E de Clercq; C A Bruggeman
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

Review 8.  Human cytomegalovirus immunity and immune evasion.

Authors:  Sarah E Jackson; Gavin M Mason; Mark R Wills
Journal:  Virus Res       Date:  2010-11-05       Impact factor: 3.303

9.  CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia.

Authors:  S J Coles; E C Y Wang; S Man; R K Hills; A K Burnett; A Tonks; R L Darley
Journal:  Leukemia       Date:  2011-01-28       Impact factor: 11.528

10.  CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells.

Authors:  Mika Pietilä; Siri Lehtonen; Elina Tuovinen; Kaarina Lähteenmäki; Saara Laitinen; Hannu-Ville Leskelä; Antti Nätynki; Juha Pesälä; Katrina Nordström; Petri Lehenkari
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

View more
  3 in total

1.  Inflammation and transcriptional responses of peripheral blood mononuclear cells in classic ataxia telangiectasia.

Authors:  Sharon A McGrath-Morrow; Roland Ndeh; Joseph M Collaco; Cynthia Rothblum-Oviatt; Jennifer Wright; Michael A O'Reilly; Benjamin D Singer; Howard M Lederman
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

Review 2.  Cross-Talk Between Alveolar Macrophages and Lung Epithelial Cells is Essential to Maintain Lung Homeostasis.

Authors:  Elyse Y Bissonnette; Jean-François Lauzon-Joset; Jason S Debley; Steven F Ziegler
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

3.  Adipose tissue-derived mesenchymal stem cells reduce endometriosis cellular proliferation through their anti-inflammatory effects.

Authors:  Fatma Y Meligy; Dalia A Elgamal; Lobna A Abdelzaher; Maha Y Khashbah; Mohamed A El-Mokhtar; Ayat A Sayed; Abeer M Refaiy; Essam R Othman
Journal:  Clin Exp Reprod Med       Date:  2021-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.